Search research articles
Contact Us
Filters
Showing results (121-130 of 154) with videos related to
Page
of 16
Sort By:
Hematological Oncology
|
September 30, 2022
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi
Emanuele Cencini, Alessandra Tucci, Benedetta Puccini, et al.
Hemasphere
|
August 18, 2025
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party
Philipp Berning, Maud Ngoya, Won Seog Kim, et al.
Hematological Oncology
|
July 17, 2010
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome
Ekaterina Chigrinova, Michael Mian, Marta Scandurra, et al.
Leukemia & Lymphoma
|
April 5, 2018
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi
Francesco Zaja, Flavia Salvi, Maura Rossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial
Sara Galimberti, Stefano Luminari, Elena Ciabatti, et al.
Haematologica
|
November 17, 2022
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
Alessandra Tucci, Francesco Merli, Alberto Fabbri, et al.
Blood Advances
|
January 5, 2024
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma
Annarita Conconi, Annalisa Chiappella, Andrés J M Ferreri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2017
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy
Emanuele Zucca, Annarita Conconi, Giovanni Martinelli, et al.
Lancet (London, England)
|
December 10, 2025
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial
Lorenzo Falchi, Marcel Nijland, Huiqiang Huang, et al.
Hematological Oncology
|
May 13, 2025
Comparative Effectiveness of R-miniCOMP Versus R-miniCHOP in Older Non-Fit Patients With Diffuse Large B-Cell Lymphoma: Insights From a "Fondazione Italiana Linfomi" Cohort Study
Alberto Bavieri, Sara Veronica Usai, Michele Merli, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 154) with videos related to
Sort By:
Page
of 16
Hematological Oncology
|
September 30, 2022
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi
Emanuele Cencini, Alessandra Tucci, Benedetta Puccini, et al.
Hemasphere
|
August 18, 2025
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party
Philipp Berning, Maud Ngoya, Won Seog Kim, et al.
Hematological Oncology
|
July 17, 2010
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome
Ekaterina Chigrinova, Michael Mian, Marta Scandurra, et al.
Leukemia & Lymphoma
|
April 5, 2018
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi
Francesco Zaja, Flavia Salvi, Maura Rossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial
Sara Galimberti, Stefano Luminari, Elena Ciabatti, et al.
Haematologica
|
November 17, 2022
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
Alessandra Tucci, Francesco Merli, Alberto Fabbri, et al.
Blood Advances
|
January 5, 2024
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma
Annarita Conconi, Annalisa Chiappella, Andrés J M Ferreri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2017
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy
Emanuele Zucca, Annarita Conconi, Giovanni Martinelli, et al.
Lancet (London, England)
|
December 10, 2025
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial
Lorenzo Falchi, Marcel Nijland, Huiqiang Huang, et al.
Hematological Oncology
|
May 13, 2025
Comparative Effectiveness of R-miniCOMP Versus R-miniCHOP in Older Non-Fit Patients With Diffuse Large B-Cell Lymphoma: Insights From a "Fondazione Italiana Linfomi" Cohort Study
Alberto Bavieri, Sara Veronica Usai, Michele Merli, et al.
Page
of 16